Age- and sex-matched non-diabetic control volunteers were selected after responding to print advertisements
Although this study contributes to the growing evidence supporting a dermatologic role for GLP-1-based therapies, larger controlled trials are needed to confirm these observations, clarify underlying mechanisms, and inform their integration into routine dermatologic practice
Frequently asked questions If youve been on a therapeutic dose for several months and havent noticed any reduction in appetite, cravings, or weight (even with consistent lifestyle efforts), it may be worth discussing with your healthcare provider
Retatrutide is an emerging medication that targets three hormone receptors instead of two, which early studies suggest may produce even stronger metabolic and weight-loss effects
The lower end prices are typically for in-clinic and the higher end pricing is typically for mobile injection services
[GLP-1 meds] are a game changer, says Michael Treskow, partner at Eight Roads Ventures, adding it would be strange if a startup working in the weight loss space wasnt looking into how they could add the drugs into their offering